Agenus Inc
AGEN
ISIN US00847G8042 / Valor 134326284
Agenus Inc
UMushroom community rating:
About company
Agenus Inc is a biotechnology firm focused on the discovery, manufacturing, and development of immuno-oncology (I-O) therapeutics. The company aims to enhance the efficacy of cancer treatments by employing a comprehensive approach that includes a variety of therapeutic modalities. These include a broad array of antibody therapeutics, adoptive cell therapies—which are advanced through its subsidiary MiNK Therapeutics—as well as adjuvants and vaccines, developed with the expertise of another subsidiary, SaponiQx. Agenus's strategy revolves around leveraging these diverse platforms to develop combination therapies that can potentially benefit a wider patient population by targeting various aspects of the immune system to fight cancer more effectively.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1766 M
Market cap (USD)
177,654
Daily traded volume (Shares)
2.875 / 2.61
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
